2021 Q1 Form 10-Q Financial Statement

#000162828021010160 Filed on May 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $280.6M $318.6M
YoY Change -11.92% -21.94%
Cost Of Revenue $98.16M $118.0M
YoY Change -16.8% -11.43%
Gross Profit $182.4M $200.6M
YoY Change -9.05% -27.0%
Gross Profit Margin 65.02% 62.97%
Selling, General & Admin $117.8M $138.9M
YoY Change -15.15% -2.42%
% of Gross Profit 64.58% 69.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $19.70M $37.80M
YoY Change -47.88% -114.68%
% of Gross Profit 10.8% 18.84%
Operating Expenses $117.8M $138.9M
YoY Change -15.15% -28.72%
Operating Profit $64.63M $61.64M
YoY Change 4.84% -22.95%
Interest Expense $15.67M $19.93M
YoY Change -21.36% -189.37%
% of Operating Profit 24.25% 32.33%
Other Income/Expense, Net -$1.093M $900.0K
YoY Change -221.44% -150.0%
Pretax Income $48.32M $41.51M
YoY Change 16.39% -16.31%
Income Tax $11.81M -$13.41M
% Of Pretax Income 24.44% -32.3%
Net Earnings $36.51M $28.10M
YoY Change 29.91% -18.54%
Net Earnings / Revenue 13.01% 8.82%
Basic Earnings Per Share $1.10 $0.86
Diluted Earnings Per Share $1.07 $0.80
COMMON SHARES
Basic Shares Outstanding 33.11M shares 32.58M shares
Diluted Shares Outstanding 34.01M shares 35.03M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.80M $1.200M
YoY Change 2383.33%
Cash & Equivalents $29.84M $1.203M
Short-Term Investments
Other Short-Term Assets $60.60M $58.70M
YoY Change 3.24%
Inventory
Prepaid Expenses
Receivables $354.7M $380.2M
Other Receivables $9.200M $36.30M
Total Short-Term Assets $463.6M $476.4M
YoY Change -2.68%
LONG-TERM ASSETS
Property, Plant & Equipment $123.3M $137.5M
YoY Change -10.34%
Goodwill $679.6M
YoY Change
Intangibles $145.6M
YoY Change
Long-Term Investments
YoY Change
Other Assets $34.41M $11.80M
YoY Change 191.61%
Total Long-Term Assets $1.081B $877.4M
YoY Change 23.19%
TOTAL ASSETS
Total Short-Term Assets $463.6M $476.4M
Total Long-Term Assets $1.081B $877.4M
Total Assets $1.544B $1.354B
YoY Change 14.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.98M $14.00M
YoY Change 42.72%
Accrued Expenses $157.5M $169.2M
YoY Change -6.89%
Deferred Revenue $47.91M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $70.00M $600.0K
YoY Change 11566.67%
Total Short-Term Liabilities $346.2M $260.1M
YoY Change 33.09%
LONG-TERM LIABILITIES
Long-Term Debt $650.2M $752.9M
YoY Change -13.64%
Other Long-Term Liabilities $48.95M $268.1M
YoY Change -81.74%
Total Long-Term Liabilities $969.1M $1.021B
YoY Change -5.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $346.2M $260.1M
Total Long-Term Liabilities $969.1M $1.021B
Total Liabilities $1.315B $1.320B
YoY Change -0.35%
SHAREHOLDERS EQUITY
Retained Earnings -$358.3M
YoY Change
Common Stock $598.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $468.6M
YoY Change
Treasury Stock Shares 26.68M shares
Shareholders Equity $229.2M $33.89M
YoY Change
Total Liabilities & Shareholders Equity $1.544B $1.354B
YoY Change 14.08%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $36.51M $28.10M
YoY Change 29.91% -18.54%
Depreciation, Depletion And Amortization $19.70M $37.80M
YoY Change -47.88% -114.68%
Cash From Operating Activities $14.20M $45.64M
YoY Change -68.88% -134.01%
INVESTING ACTIVITIES
Capital Expenditures -$3.700M -$9.100M
YoY Change -59.34% -201.11%
Acquisitions $174.2M $0.00
YoY Change
Other Investing Activities -$174.2M $1.500M
YoY Change -11713.33% -134.88%
Cash From Investing Activities -$177.9M -$7.620M
YoY Change 2234.09% -262.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $21.77M
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $191.8M -$38.73M
YoY Change -595.2% -109.99%
NET CHANGE
Cash From Operating Activities $14.20M $45.64M
Cash From Investing Activities -$177.9M -$7.620M
Cash From Financing Activities $191.8M -$38.73M
Net Change In Cash $27.44M -$709.0K
YoY Change -3969.53% -100.27%
FREE CASH FLOW
Cash From Operating Activities $14.20M $45.64M
Capital Expenditures -$3.700M -$9.100M
Free Cash Flow $17.90M $54.74M
YoY Change -67.29% -138.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001556739
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5555
CY2021Q1 us-gaap Defined Benefit Plan Type Extensible List
DefinedBenefitPlanTypeExtensibleList
us-gaap:PensionPlansDefinedBenefitMember
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-35895
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
THRYV HOLDINGS, INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-2740040
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2200 West Airfield Drive, P.O. Box 619810
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
D/FW Airport
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75261
CY2021Q1 dei City Area Code
CityAreaCode
(972)
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
453-7000
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2021Q1 dei Trading Symbol
TradingSymbol
THRY
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33685958 shares
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
280606000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
318570000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
98160000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
117976000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
182446000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
200594000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
76540000 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
89292000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41279000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
49562000 USD
CY2021Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
98000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
117819000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
138952000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
64627000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
61642000 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
11607000 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
14780000 USD
CY2021Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4065000 USD
CY2020Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
5150000 USD
CY2021Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-453000 USD
CY2020Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
201000 USD
CY2021Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1093000 USD
CY2020Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48315000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41511000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11809000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13409000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
36506000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
28102000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.10
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33108422 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32578286 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34013480 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35026526 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
36506000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
28102000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2967000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33539000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
28102000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29841000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2406000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34557000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
33030000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
354737000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
296570000 USD
CY2021Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
244000 USD
CY2020Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
338000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
9285000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
10975000 USD
CY2021Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
9154000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
9229000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36277000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26172000 USD
CY2021Q1 dxm Indemnification Asset Current
IndemnificationAssetCurrent
24346000 USD
CY2020Q4 dxm Indemnification Asset Current
IndemnificationAssetCurrent
24346000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
463640000 USD
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Assets Current
AssetsCurrent
369698000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
123281000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89044000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
679559000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
609457000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
145647000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
31777000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
97941000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
93099000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34410000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21902000 USD
CY2021Q1 us-gaap Assets
Assets
1544478000 USD
CY2020Q4 us-gaap Assets
Assets
1214977000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
19981000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8927000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
157537000 USD
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59806077 shares
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
139613000 USD
CY2021Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
30417000 USD
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
30022000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
47909000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18942000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
70000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20324000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9896000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
346168000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
207400000 USD
CY2021Q1 us-gaap Senior Long Term Notes
SeniorLongTermNotes
372454000 USD
CY2021Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
234098000 USD
CY2020Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
335683000 USD
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
113482000 USD
CY2021Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
43682000 USD
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33127667 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59590422 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32912012 shares
CY2020Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
79238000 USD
CY2021Q1 dxm Financing Obligations Noncurrent
FinancingObligationsNoncurrent
54585000 USD
CY2020Q4 dxm Financing Obligations Noncurrent
FinancingObligationsNoncurrent
54798000 USD
CY2021Q1 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
184642000 USD
CY2020Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
190827000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
30706000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
508000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
48947000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
36266000 USD
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
969114000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
810802000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1058504000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1059624000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
598000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
596000 USD
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
26678410 shares
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
26678410 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
468613000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
468613000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2967000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-358326000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-394832000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
229196000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
196775000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1544478000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1214977000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
196775000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-3094000 USD
CY2021Q1 dxm Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
5000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1971000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
36506000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
229196000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
27260000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
21770000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
300000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
28102000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
33892000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
36506000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
28102000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19718000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37823000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
433000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
267000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-13249000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15911000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2018000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10588000 USD
CY2021Q1 dxm Provision For Service Credits
ProvisionForServiceCredits
4528000 USD
CY2020Q1 dxm Provision For Service Credits
ProvisionForServiceCredits
6736000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1971000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-6064000 USD
CY2021Q1 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
-453000 USD
CY2020Q1 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
201000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-299000 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-15000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2962000 USD
CY2021Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
98000 USD
CY2021Q1 dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
0 USD
CY2020Q1 dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-3801000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-835000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-26846000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8921000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-1446000 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
522000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10998000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4583000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-67458000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-33981000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
9597000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
30351000 USD
CY2021Q1 dxm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-403000 USD
CY2020Q1 dxm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2620000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2547000 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2685000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14204000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45642000 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3668000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
9122000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1502000 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
174190000 USD
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-177858000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7620000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
418070000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
CY2021Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
260930000 USD
CY2020Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2021Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
335821000 USD
CY2020Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
23445000 USD
CY2021Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
113789000 USD
CY2020Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
10555000 USD
CY2021Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
249936000 USD
CY2020Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
329719000 USD
CY2021Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
285492000 USD
CY2020Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
312624000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
21770000 USD
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2038000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-56000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
191796000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38731000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-707000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
27435000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-709000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2406000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1912000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29841000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1203000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
17286000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
20802000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15753000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1031000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
117976000 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
89292000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
49562000 USD
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
98000 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s condensed consolidated financial statements requires management to make estimates and assumptions about future events that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. The results of those estimates form the basis for making judgments about the carrying values of certain assets and liabilities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of reported amounts that rely on significant estimates include revenue recognition, allowance for credit losses, assets acquired and liabilities assumed in business combinations, capitalized costs to obtain a contract, certain amounts relating to the accounting for income taxes, including valuation allowance, indemnification asset, stock-based compensation expense, operating lease right-of-use assets and operating lease liabilities, accrued service credits, and net pension obligation. Significant estimates are also used in determining the recoverability and fair value of fixed assets and capitalized software, operating lease right-of-use assets, goodwill, and intangible assets.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the novel strain of coronavirus, commonly referred to as COVID-19 (“</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”) and the uncertainty of the extent of the impacts related thereto, certain estimates and assumptions may require increased judgment. As events continue to evolve and additional information becomes available, these estimates may change in future periods. It is difficult to predict what the ongoing impact of the pandemic will be on future periods.</span></div>
CY2021Q1 us-gaap Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
15400000 USD
CY2021Q1 us-gaap Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
-4000000.0 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4700000 USD
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6200000 USD
CY2021Q1 dxm Revenue From Contract With Customer Excluding Assessed Tax Covid19 Credits
RevenueFromContractWithCustomerExcludingAssessedTaxCOVID19Credits
2200000 USD
CY2020Q1 dxm Revenue From Contract With Customer Excluding Assessed Tax Covid19 Credits
RevenueFromContractWithCustomerExcludingAssessedTaxCOVID19Credits
700000 USD
CY2020Q1 dxm Deferred Compensation And Unrecognized Share Based Arrangements Liability Fair Value Disclosure
DeferredCompensationAndUnrecognizedShareBasedArrangementsLiabilityFairValueDisclosure
49100000 USD
CY2020Q1 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
36700000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2000000.0 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-6100000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
609457000 USD
CY2021Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
71722000 USD
CY2021Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1620000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
679559000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1049939000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
901314000 USD
CY2021Q1 dxm Finite Lived Intangible Assets Accumulated Foreign Currency Gain Loss
FiniteLivedIntangibleAssetsAccumulatedForeignCurrencyGainLoss
2979000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
145647000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P3Y2M12D
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
923199000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
891422000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
31777000 USD
CY2020 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P2Y
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9900000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28900000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
63648000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
51014000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
21979000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9006000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
145647000 USD
CY2020Q4 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
33368000 USD
CY2019Q4 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
26828000 USD
CY2021Q1 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss Increase Due To Acquisition
AccountsReceivableAndContractWithCustomerAllowanceForCreditLossIncreaseDueToAcquisition
2733000 USD
CY2021Q1 dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
2018000 USD
CY2020Q1 dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
10588000 USD
CY2021Q1 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss Writeoff
AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteoff
3318000 USD
CY2020Q1 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss Writeoff
AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteoff
3630000 USD
CY2021Q1 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
34801000 USD
CY2020Q1 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
33786000 USD
CY2021Q1 dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
2000000.0 USD
CY2020Q1 dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
10600000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
34600000 USD
CY2021Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
200000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
33500000 USD
CY2020Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
300000 USD
CY2020Q1 dxm Accounts Receivable Allowance For Credit Loss Incremental Increase Decrease Due To Covid19
AccountsReceivableAllowanceForCreditLossIncrementalIncreaseDecreaseDueToCOVID19
3100000 USD
CY2021Q1 dxm Accounts Receivable Allowance For Credit Loss Incremental Increase Decrease Due To Covid19
AccountsReceivableAllowanceForCreditLossIncrementalIncreaseDecreaseDueToCOVID19
0 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
49708000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
53844000 USD
CY2021Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1293000 USD
CY2020Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2280000 USD
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
36385000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
26209000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
64940000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
51284000 USD
CY2021Q1 dxm Accrued Service Credits Current
AccruedServiceCreditsCurrent
5211000 USD
CY2020Q4 dxm Accrued Service Credits Current
AccruedServiceCreditsCurrent
5996000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
157537000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
139613000 USD
CY2021Q1 us-gaap Severance Costs1
SeveranceCosts1
600000 USD
CY2020Q1 us-gaap Severance Costs1
SeveranceCosts1
3300000 USD
CY2020Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
2700000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
720234000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
528403000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
70000000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
650234000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
528403000 USD
CY2021Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4100000 USD
CY2020Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
5200000 USD
CY2021Q1 us-gaap Interest Payable Current
InterestPayableCurrent
6500000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
8500000 USD
CY2021Q1 dxm Financing Obligations Noncash Residual Value Of Failed Sale Leaseback Transaction
FinancingObligationsNoncashResidualValueOfFailedSaleLeasebackTransaction
54676000 USD
CY2020Q4 dxm Financing Obligations Noncash Residual Value Of Failed Sale Leaseback Transaction
FinancingObligationsNoncashResidualValueOfFailedSaleLeasebackTransaction
54676000 USD
CY2021Q1 dxm Financing Obligations Minimum Lease Payments Failed Sale Leaseback Transaction
FinancingObligationsMinimumLeasePaymentsFailedSaleLeasebackTransaction
691000 USD
CY2020Q4 dxm Financing Obligations Minimum Lease Payments Failed Sale Leaseback Transaction
FinancingObligationsMinimumLeasePaymentsFailedSaleLeasebackTransaction
862000 USD
CY2021Q1 dxm Financing Obligations
FinancingObligations
55367000 USD
CY2020Q4 dxm Financing Obligations
FinancingObligations
55538000 USD
CY2021Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2616000 USD
CY2020Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
4234000 USD
CY2021Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2890000 USD
CY2020Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
4033000 USD
CY2021Q1 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
15000 USD
CY2020Q1 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
0 USD
CY2021Q1 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
164000 USD
CY2020Q1 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
0 USD
CY2021Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-453000 USD
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1000000.0 shares
CY2020Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
201000 USD
CY2020Q1 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
0 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
215544 shares
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1971000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-6064000 USD
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10500000 shares
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10500000 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5800000 shares
CY2021Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5800000 shares
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
24.39
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
24.39
CY2021Q1 dxm Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights During Period
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsDuringPeriod
200 shares
CY2020Q1 dxm Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights During Period
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsDuringPeriod
0 shares
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
800000 shares
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12600000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9200000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
36506000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
28102000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33108422 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32578286 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.10
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
36506000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
28102000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33108422 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32578286 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
905058 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2448240 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34013480 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35026526 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.323
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23700000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
23700000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
23700000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
23700000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
8800000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
8400000 USD
CY2021Q1 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
21800000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
1000000.0 USD
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
280606000 USD
CY2021Q1 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
104933000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
318570000 USD
CY2020Q1 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
112779000 USD
CY2021Q1 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
104933000 USD
CY2020Q1 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
112779000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
15672000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
19930000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19718000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37823000 USD
CY2021Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
-453000 USD
CY2020Q1 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
201000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-299000 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
98000 USD
CY2021Q1 dxm Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
9234000 USD
CY2020Q1 dxm Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
9845000 USD
CY2021Q1 dxm Transaction Costs
TransactionCosts
10546000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
318570000 USD
CY2020Q1 dxm Transaction Costs
TransactionCosts
6534000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1971000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-6064000 USD
CY2021Q1 dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
0 USD
CY2020Q1 dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-3801000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
369000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
900000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48315000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41511000 USD
CY2021Q1 us-gaap Severance Costs1
SeveranceCosts1
600000 USD
CY2020Q1 us-gaap Severance Costs1
SeveranceCosts1
3300000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
280606000 USD

Files In Submission

Name View Source Status
0001628280-21-010160-index-headers.html Edgar Link pending
0001628280-21-010160-index.html Edgar Link pending
0001628280-21-010160.txt Edgar Link pending
0001628280-21-010160-xbrl.zip Edgar Link pending
dxm-20210331.htm Edgar Link pending
dxm-20210331.xsd Edgar Link pending
dxm-20210331_cal.xml Edgar Link unprocessable
dxm-20210331_def.xml Edgar Link unprocessable
dxm-20210331_htm.xml Edgar Link completed
dxm-20210331_lab.xml Edgar Link unprocessable
dxm-20210331_pre.xml Edgar Link unprocessable
exhibit311-q12021.htm Edgar Link pending
exhibit312-q12021.htm Edgar Link pending
exhibit321-q12021.htm Edgar Link pending
exhibit322-q12021.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending